Op-Art: Drug Price Controls vs. the NIH “Cancer Moonshot” Initiative

Robert D. Atkinson February 21, 2022
February 21, 2022

(Ed. Note: The “Innovation Fact of the Week” appears as a regular feature in each edition of ITIF’s weekly email newsletter. Sign up today.)

Twitter Image: 
Op-Art: Drug Price Controls vs. the NIH “Cancer Moonshot” Initiative

Related ITIF Content

November 22, 2021
Drug Price Controls Are Bad Policy. Congress Should Instead Double Down on Innovation to Boost Productivity in Biopharma R&D
May 20, 2021
Five Fatal Flaws in Rep. Katie Porter’s Indictment of the U.S. Drug Industry
September 9, 2019
The Link Between Drug Prices and Research on the Next Generation of Cures